HDx therapy delivers meaningful and relevant innovation for dialysis patients.
While HDx therapy may offer the potential to improve access to care and to help improve the effectiveness and quality of care, HDx therapy may simultaneously offer dialysis service providers and healthcare systems alike the opportunity to reduce the total cost of care.1,2
Importance of Economics
A reduction in hospitalization and medication usage, may significantly reduce the total cost of care to a Payer and/or Provider.
Primary clinical studies illuminate the benefits of HDx therapy enabled by Theranova
Bunch A et al. Medium cut-off dialyzers in a large population of hemodialysis patients in Colombia: COREXH Registry.
Hospitalization length of stay may be reduced when prescribing HDx therapy enabled by Theranova compared to conventional hemodialysis.3
Ariza et al. Measuring the association of switching patients from hemodialysis to expanded hemodialysis, with hospitalizations, medication use, costs and patient utility.
Medication usage, particularly erithropoyesis stimulating agents, iron, insulin, and hypertension medications, may be reduced when prescribing HDx therapy rather than conventional hemodialysis.1
Blackowicz MJ et al. Health Economic Evaluation of the Theranova 400 Dialyzer among Hemodialysis Patients in the US.
In addition to Theranova's superior removal of large middle molecules, Theranova may also be a cost-saving therapy to the US healthcare system driven largely by reduction in patient hospitalization events. All-cause hospitalization rate was 43% lower with Theranova dialyzer compared with a high flux membrane.2
Ariza JG et al. Measuring the association of switching patients from hemodialysis to expanded hemodialysis, with hospitalizations, medication use, costs and patient utility.
HDx therapy enabled by Theranova may significantly reduce hospitalization length of stay in a real-world setting when compared to conventional hemodialysis.1
Provide Expanded Hemodialysis. Retain HD Simplicity.
Hear from patients, nephrologists, and nurses alike share their experience prescribing HDx. Be reassured by the pioneering commitment of Baxter to dialysis patients the world over and learn how Theranova dialyzers are made.
HDx Evidence Compendium
On-going research and clinical reporting are an integral part of the HDx journey. Explore the expanding evidence related to HDx enabled by Theranova that nephrologists around the world continue to generate.
HDx Therapy Brochure
Here you can find the HDx therapy brochure with more information about prescribing HDx for your hemodialysis patients.
HDx Therapy Specification Sheets
Here you can find the detailed profiles of Theranova dialyzers.
Important Safety Information
Theranova dialyzers are indicated for treatment of chronic and acute renal failure by hemodialysis.
*Do not use Theranova dialyzers in HDF or HF mode.
For safe and proper use of this device, please refer to Instructions for Use.